S. 2495 — Protecting our Pharmaceutical Supply Chain from China Act of 2021

“A bill to require the Secretary of Health and Human Services to maintain a list of the country of origin of all drugs marketed in the United States, to ban the use of Federal funds for the purchase of drugs manufactured in the People's Republic of China, and for other purposes.”